
Read More
Pharma Major Cipla Reports Q1 FY27 Results; Net Profit Declines 39% YoY Des...
Cipla reported a modest increase in revenue during Q1 FY27, while profitability declined on a high b...

Cipla reported a modest increase in revenue during Q1 FY27, while profitability declined on a high b...

Cipla reported Q4FY26 revenue of Rs 6,541 crore with EBITDA margin at 15.2 per cent, while the compa...

Founded in 1935, Cipla is a global pharmaceutical leader driven by its core purpose of "Caring for L...

This has been notified of a temporary suspension in the production of Lanreotide Injection....

The company has a market cap of over Rs 1 lakh crore and the stock is up by 13 per cent from its 52-...

Watch out for these large-cap stocks in Thursday’s trading session!...